The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity

Doxorubicin is a commonly used chemotherapeutic agent for the treatment of a range of cancers, but despite its success in improving cancer survival rates, doxorubicin is cardiotoxic and can lead to congestive heart failure. Therapeutic options for this patient group are limited to standard heart fai...

Descripción completa

Detalles Bibliográficos
Autores principales: Timm, Kerstin N., Tyler, Damian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125062/
https://www.ncbi.nlm.nih.gov/pubmed/32034646
http://dx.doi.org/10.1007/s10557-020-06941-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125062/
https://www.ncbi.nlm.nih.gov/pubmed/32034646
http://dx.doi.org/10.1007/s10557-020-06941-x

Ejemplares similares